Regulatory feed
Published med-spa & injectable compliance alerts · monitoring, not legal advice
Free weekly Brief
Get the changes that matter in plain English, every week — and be alerted when the rules move. No charge.
Members get a specific “what to do” wherever a change calls for one — in one daily email, for your states. See one unlocked → · Pricing →
Border enforcement · last 90 days
FDA Import Refusals · counts of published records
FDA refused 129 shipments of unapproved or violative injectables at the U.S. border from 90 firms across 20 countries — the gray-market corridor to source away from.
| Product class | Shipments | Firms | Countries |
|---|---|---|---|
| Dermal fillersincl. COMEM NATURAL JSC, DIVES MED GMBH SCHONHAUSER, Merz Pharmaceuticals GmbH | 76 | 54 | 15 |
| Botulinum toxinincl. EKAI ELECTRONIC TECHNOLOGY CO LT, Ipsen Biopharm Ltd, TRAN THI THU HIEN | 34 | 23 | 9 |
| GLP-1 drugsincl. TANDJIGORA MOHAMED, MITSUBISHI TANABE PHARMA CORPORATION ., ELI LILLY JAPAN | 10 | 8 | 6 |
| Injectable anestheticsincl. CIMERA CARE PVT LTD, Mcgill University, PRAISE PHARMA | 9 | 9 | 5 |
Source: FDA Data Dashboard import refusals. A refusal is a border action, not a finding against any U.S. practice. Named firms are the foreign shippers/manufacturers on FDA’s record.
Showing everything, including routine background items (bulk import refusals, inspection citations).
Show material only →- MONITORFEDAesthetic InjectablesNov 5, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (China)
FDA refused entry of OnabotulinumtoxinA from China; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · EKAI ELECTRONIC TECHNOLOGY CO LT · Guangzhou · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesNov 5, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Vietnam)
FDA refused entry of Vietnamese collagen dermal implants; check violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · COMEM NATURAL JSC · Ha Noi · plastic-surgery device · refused entry by FDA
- MONITORWAScope of PracticeNov 4, 2026
WA State Health Agency: Ambulatory Surgical Facility Fees
Washington establishes new fees for licensing ambulatory surgical facilities.
What to do — members only.Become a member →State Health Agencyprimary source ↗ - MONITORFEDAesthetic InjectablesNov 4, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Germany)
FDA refused entry of collagen implants from Germany; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · DIVES MED GMBH SCHONHAUSER · Berlin · plastic-surgery device · refused entry by FDA
- MONITORWAScope of PracticeNov 4, 2026
WA State Health Agency: Osteopathic Physician Protected Title Interpretive Statement OP26-01
Washington's OP26-01 clarifies title protections for osteopathic physicians.
What to do — members only.Become a member →State Health Agencyprimary source ↗ - MONITORFEDAesthetic InjectablesNov 4, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (United Kingdom)
FDA refusal of ONABOTULINUMTOXINA from the UK; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Ipsen Biopharm Ltd · Berkshire · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesNov 4, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (China)
FDA refused entry of onabotulinumtoxinA from China as violative.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · EKAI ELECTRONIC TECHNOLOGY CO LT · Guangzhou · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesNov 3, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refused entry of collagen dermal implants from Sweden due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesNov 3, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Germany)
FDA refused entry of dermal collagen implants from Germany; effective Nov 3, 202
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz Pharmaceuticals GmbH · Frankfurt Am Main · plastic-surgery device · refused as adulteration, misbranding
- MONITORFEDNeuromodulatorsOct 30, 2026
Primary Source Monitoring: Botox Fraud Doctor Sentenced to 15 Years in Prison for $45M Medicare Scheme
California doctor sentenced for $45 million Botox fraud scheme.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORUTPeptidesOct 30, 2026
UT State Licensing Agency: Peptide Enforcement Discretion Policy
Utah's Peptide Enforcement Discretion Policy outlines enforcement guidelines.
What to do — members only.Become a member →State Licensing Agencyprimary source ↗ - MONITORFEDGLP-1 CompoundingOct 28, 2026
Primary Source Monitoring: Drug Approvals and Databases
FDA updates drug approval databases, impacting supply chains.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesFDA: VAIOct 28, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use
FDA refused entry of collagen implants from Wisconsin; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz North America, Inc. · Franksville · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesOct 28, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Vietnam)
FDA has refused entry of OnabotulinumtoxinA from Vietnam; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · TRAN THI THU HIEN · Ha Noi City · drug product · refused as misbranding, unapproved new drug
- MONITORWAScope of PracticeOct 26, 2026
WA State Health Agency: Allopathic Physician and Surgeon, Physician Assistant, and Anesthesiologist Assistant Fees
Washington State adjusts licensing fees for medical professionals.
What to do — members only.Become a member →State Health Agencyprimary source ↗ - MONITORFEDAesthetic InjectablesOct 26, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (United Kingdom)
FDA refused entry of UK-sourced collagen dermal implants on Oct 26, 2026.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · MERZ PHARMA · Hemel Hempstead · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesOct 26, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refused entry of collagen dermal implants from Sweden; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingOct 26, 2026
Primary Source Monitoring: Statement on improving adverse event reporting of compounded drugs to protect patients
FDA urges better reporting for compounded drug adverse events.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesOct 26, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of collagen implants from South Korea; check your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · CSBIO · Gyeonggi-Do · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIOct 26, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refused entry of OnabotulinumtoxinA from South Korea on Oct 26, 2026.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) · Hwaseong · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesOct 26, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refused entry of dermal collagen implants from France; confirm violation.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · J-DERM ULTRA SMILE · Annecy · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIOct 23, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Canada)
FDA refused entry of collagen implants from Ontario as violative.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Prollenium Medical Technologies Inc. · Aurora · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesOct 23, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refused entry of OnabotulinumtoxinA from South Korea; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Pharmaceutical Co. , Ltd · Seoul · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesOct 23, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (China)
FDA refused entry of collagen dermal implants from China on Oct 23, 2026.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · EKAI ELECTRONIC TECHNOLOGY CO LT · Guangzhou · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesOct 23, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses ONABOTULINUMTOXINA from South Korea; verify your supplier.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · DAEWOONG PHARMACEUTICAL CO LTD · SEOUL · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesOct 23, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of collagen dermal implants from South Korea on Oct 23, 2026.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · PRP Science Co., Ltd · Hwaseong · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesOct 23, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Switzerland)
FDA refused entry of collagen dermal implants from Geneva, Switzerland.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Teoxane S.A. · Geneva · plastic-surgery device · refused as misbranding
- CAUTIONWIScope of PracticeOct 23, 2026
WI State Administrative Register: Register 850 - Inserted Chapter De 12 - 2026-10-23
Wisconsin's Chapter DE 12 sets new delegation rules for medical practice.
What to do — members only.Become a member →State Administrative Registerprimary source ↗ - MONITORFEDAesthetic InjectablesOct 22, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of collagen dermal implants from South Korea on Oct 22, 2026.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · REANZEN CO LTD · Gyeonggi-Do · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesOct 22, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of collagen dermal implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Dongbang Medical Co. Ltd · Dongbangbaekjungang-ro · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesOct 22, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Turkey)
FDA refused entry of OnabotulinumtoxinA from Turkey; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Pharmaceuticals Trade Co. · Istanbul · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesOct 22, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of collagen dermal implants from South Korea; verify suppliers
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · JETEMA CO LTD · Yongin · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesOct 22, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of collagen dermal implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Exocobio, Inc. · Geumcheon · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIOct 22, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refused entry of onabotulinumtoxinA from South Korea on Oct 22, 2026.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) · Hwaseong · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesOct 22, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refused entry of onabotulinumtoxinA from South Korea; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · HUGEL CO LTD · Seoul · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIOct 22, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (United Kingdom)
FDA refused entry of onabotulinumtoxinA from the UK; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Ipsen BioPharm Ltd · Wrexham · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesOct 22, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of collagen dermal implants from South Korea; verify suppliers
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Across Co., Ltd · Chuncheon-si · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesOct 21, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA imports refusal data reveals a dermal implant from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ERIC EVANS · Seoul · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDGLP-1 CompoundingOct 21, 2026
Primary Source Monitoring: Compounding Quality Center of Excellence | Discussion Series
FDA's Compounding Quality Center of Excellence hosts discussions; register.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesOct 21, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (United Kingdom)
FDA refused entry for collagen dermal implants from the UK on Oct 21, 2026.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · MORIRE SMITH · London · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDMulti-topicOct 21, 2026
Primary Source Monitoring: Juarez v. San Antonio Med Spa LLC (5:26-cv-06778) — District Court, W.D. Texas
Ongoing federal case could impact Texas med spas; watch for developments.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - CAUTIONFEDGLP-1 CompoundingOct 21, 2026
FDA recall (Class II): Tirzepatide/Niacinamide 2mL vial (40 Mg per Vial) Inj 20mg/2mg/mL, Rx Only, Houston Rx LLC, 15430 Vantage Parkway E Ste…
FDA Class II recall of Tirzepatide/Niacinamide due to sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDMulti-topicOct 21, 2026
Primary Source Monitoring: Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency Issues
Wedgewood Pharmacy recalls compounded veterinary medications due to potency issu
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesOct 21, 2026
FDA import refusal: Lidocaine (Anesthetic) (India)
FDA refused entry of lidocaine from India; confirm violation details.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · CIMERA CARE PVT LTD · Uttarkand · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesOct 21, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Vietnam)
FDA refused entry of dermal collagen implants from Vietnam; check suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · (JLVN) JD Vietnam Investment Company LIMI · Long Bien · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesOct 20, 2026
FDA import refusal: Lidocaine (Anesthetic) (Canada)
FDA refused entry of lidocaine from Canada; effective Oct 20, 2026.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Mcgill University · Montreal · drug product · refused as misbranding
- MONITORFEDGLP-1 CompoundingOct 19, 2026
Primary Source Monitoring: Eli Lilly v. Instant Rx (E.D.N.Y.) — Judgment - Consent
Eli Lilly v. Instant Rx judgment may affect compounded GLP-1 practices.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDPeptidesOct 16, 2026
Primary Source Monitoring: Eli Lilly v. Lone Star Peptide (S.D. Tex.) — Notice of Dismissal
Eli Lilly's lawsuit against Lone Star Peptide dismissed.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesFDA: VAIOct 15, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refused entry of OnabotulinumtoxinA from South Korea; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) · Hwaseong · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesOct 15, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refused entry of OnabotulinumtoxinA from South Korea; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · BELOVE COSMETIC · Korea · drug product · refused as unapproved new drug
- MONITORFEDPeptidesOct 15, 2026
Primary Source Monitoring: Eli Lilly v. Texas Peptides (W.D. Tex.) — Notice of Voluntary Dismissal
Eli Lilly voluntarily dismisses lawsuit against Texas Peptides.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesOct 15, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Turkey)
FDA refused entry of collagen dermal implants from Istanbul; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ELIT PHARMA · Gaziosmanpasa · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesOct 15, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of collagen dermal implants from South Korea; verify suppliers
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Exocobio, Inc. · Geumcheon · plastic-surgery device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingOct 14, 2026
FDA recall (Class II): Tirzepatide/CYANOCOBALAMIN 85/2 MG/ML Injectable, Packaged in single-use dosage syringes, total mL dispensed based on d…
FDA recall of compounded Tirzepatide due to sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDMulti-topicOct 14, 2026
Primary Source Monitoring: Medical Spa Business Owner Pleads Guilty to Employment Tax Crimes
Medical spa owner pleads guilty to employment tax crimes; watch tax compliance.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - CAUTIONFEDGLP-1 CompoundingOct 14, 2026
FDA recall (Class II): Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, N…
Class II recall of Tirzepatide Injection over sterility concerns; initiated Sept
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingOct 14, 2026
FDA recall (Class II): Tirzepatide/CYANOCOBALAMIN 64/2 MG/ML Injectable, Packaged in single-use dosage syringes, total mL dispensed based on d…
FDA recalls injectable tirzepatide/cyanocobalamin due to sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFEDGLP-1 CompoundingOct 14, 2026
FDA recall (Class II): Semaglutide 3 MG/ML Injectable, 8 x 0.1 mL syringes, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, Sc 29936
FDA recalls compounded semaglutide for sterility concerns; initiated Sept 10, 20
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFEDGLP-1 CompoundingOct 14, 2026
FDA recall (Class II): Tirzepatide/CYANOCOBALAMIN 26/2 MG/ML Injectable, Packaged in single-use dosage syringes, total mL dispensed based on d…
FDA recalls tirzepatide/cyanocobalamin due to sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingOct 14, 2026
FDA recall (Class II): Semaglutide/CYANOCOBALAMIN 9/2 MG/ML Injectable, Packaged in single-use dosage syringes, total mL dispensed based on DO…
FDA recalls compounded semaglutide for sterility concerns; initiated Sept 10, 20
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingOct 14, 2026
FDA recall (Class II): Tirzepatide 26 MG/ML Injectable, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specifi…
FDA issues Class II recall for compounded tirzepatide; effective Sept 10, 2026.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDAesthetic InjectablesOct 14, 2026
FDA import refusal: Solution, Sodium Hyaluronate (France)
FDA refused entry of sodium hyaluronate solution from France on Oct 14, 2026.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · LE THILLAY PFC · Le Thillay · medical device · refused as misbranding
- MONITORFEDGLP-1 CompoundingOct 14, 2026
FDA recall (Class II): Semaglutide/CYANOCOBALAMIN 3/2 MG/ML Injectable, Packaged in single-use dosage syringes, total mL dispensed based on DO…
FDA recalls compounded semaglutide over sterility concerns; effective Sept 10, 2
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingOct 14, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (France)
FDA refused entry of semaglutide from France; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · TANDJIGORA MOHAMED · Aulnay Sous Bois · drug product · refused as unapproved new drug
- MONITORFEDGLP-1 CompoundingOct 14, 2026
FDA recall (Class II): Tirzepatide/CYANOCOBALAMIN 76/2 MG/ML Injectable, Packaged in single-use dosage syringes, total mL dispensed based on d…
FDA recalls Tirzepatide/Cyanocobalamin due to sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDMulti-topicOct 13, 2026
Primary Source Monitoring: Par Health Issues Voluntary Nationwide Recall of Argatroban Injection Due to the Presence of Particulate Matter
Nationwide recall of Argatroban Injection due to particulate matter.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORWIMulti-topicOct 12, 2026
WI State Administrative Register: Emergency Rules in Effect - 2026-10-12
Emergency rules enacted by the Wisconsin state board; effective Oct 12, 2026.
What to do — members only.Become a member →State Administrative Registerprimary source ↗ - MONITORFEDAesthetic InjectablesOct 9, 2026
FDA import refusal: Acid, Hyaluronic, Intraarticular (South Korea)
FDA refused entry of hyaluronic acid from South Korea; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · MEDISEPTE E&C · Seoul · medical device · refused as misbranding
- MONITORFEDAesthetic InjectablesOct 9, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of collagen implants from South Korea; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · VAIM Co., Ltd. · Daejeon · plastic-surgery device · refused as adulteration
- MONITORFEDAesthetic InjectablesOct 9, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Italy)
FDA refused entry of collagen implants from Milan; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · INFNI LAB · Milan · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesFDA: VAIOct 9, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Germany)
FDA refused entry of OnabotulinumtoxinA from Germany; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz Pharma GmbH & Co., KGaA · Dessau-Rosslau · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAIOct 8, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
OnabotulinumtoxinA from South Korea refused entry by FDA; check suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · CKD Bio Corporation · Ansan · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesOct 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of dermal collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · DONGBANG MEDICAL CO.,LTD · Yongin-Si · plastic-surgery device · refused as misbranding, adulteration, unapproved new drug
- MONITORFEDAesthetic InjectablesOct 8, 2026
FDA import refusal: Triamcinolone Acetonide (Glucocorticoid) (Bangladesh)
Triamcinolone acetonide from Bangladesh refused entry by FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · PRAISE PHARMA · Dhaka · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesOct 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of collagen dermal implants from South Korea on Oct 8, 2026.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · PharmaResearch BIO Co., Ltd. · Gangreung · plastic-surgery device · refused as misbranding, adulteration, unapproved new drug
- MONITORFEDAesthetic InjectablesOct 8, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Germany)
FDA refused entry of OnabotulinumtoxinA from Germany; verify sourcing.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz Pharmaceuticals GmbH · Frankfurt Am Main · drug product · refused as misbranding, adulteration, unapproved new drug
- MONITORFEDAesthetic InjectablesOct 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refused entry of collagen dermal implants from Sweden; confirm violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused as misbranding, adulteration, unapproved new drug
- MONITORFEDPeptidesOct 8, 2026
Primary Source Monitoring: Eli Lilly & Co v. American Peptides L L C (5:26-cv-04146) — District Court, W.D. Louisiana
Eli Lilly's lawsuit against American Peptides raises concerns for suppliers.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesFDA: VAIOct 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use
FDA refused entry of an injectable collagen implant; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz North America, Inc. · Franksville · plastic-surgery device · refused as misbranding, adulteration, unapproved new drug
- MONITORFEDAesthetic InjectablesOct 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of dermal collagen implants from South Korea; verify suppliers
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · DEXLEVO · Goyang Gyeonggi · plastic-surgery device · refused as misbranding, adulteration, unapproved new drug
- MONITORFEDAesthetic InjectablesOct 8, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Singapore)
FDA refused entry of onabotulinumtoxinA from Singapore on Oct 8, 2026.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · LINH HUNG COMPANY · Singapore · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesOct 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Italy)
FDA refused entry of an injectable collagen implant from Italy on Oct 8, 2026.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · IBSA Farmaceutici Italia Srl · Lodi · plastic-surgery device · refused as misbranding, adulteration, unapproved new drug
- MONITORFEDAesthetic InjectablesOct 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of collagen implants from South Korea; confirm violation.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · GCS CO LTD · Seongnam · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesFDA: VAIOct 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refused entry of a collagen dermal implant from Savoy, France.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Industrie SAS · Pringy · plastic-surgery device · refused as misbranding, adulteration, unapproved new drug
- MONITORFEDAesthetic InjectablesOct 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of collagen dermal implants from South Korea; verify suppliers
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Across Co., Ltd · Chuncheon-si · plastic-surgery device · refused as misbranding, adulteration, unapproved new drug
- MONITORFEDGLP-1 CompoundingOct 7, 2026
Primary Source Monitoring: Eli Lilly v. DrugPlace (S.D. Fla.) — Order on Motion for Miscellaneous Relief and Order on Motion to Dismiss and Order on Motion to Dismiss and Order…
Eli Lilly v. DrugPlace raises compliance concerns for GLP-1 suppliers.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - CAUTIONWIScope of PracticeOct 5, 2026
Source review pending
This item is withheld pending independent source review.
Review pending — this item is withheld while its source and final wording are independently checked.
State Administrative Registerprimary source ↗ - MONITORWIMulti-topicOct 5, 2026
WI State Administrative Register: Emergency Rules in Effect - 2026-10-05
Wisconsin emergency rules effective October 5, 2026, need review by med spas.
What to do — members only.Become a member →State Administrative Registerprimary source ↗ - CAUTIONFEDMulti-topicOct 1, 2026
FDA Warning Letter: Zhejiang Gaorong Cosmetic Co., Ltd (Drugs)
Zhejiang Gaorong Cosmetic Co., Ltd received an FDA Warning Letter on Oct 1, 2026
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORFEDGLP-1 CompoundingOct 1, 2026
Primary Source Monitoring: Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levels
Greenwich Rx recalls specific glutathione lots: potential endotoxin elevation.
Review pending — this item’s action instruction is withheld while it is checked against the primary source.
Primary Source Monitoringprimary source ↗ - CAUTIONFEDMulti-topicOct 1, 2026
FDA Warning Letter: RoyceDerm, LLC (Drugs)
RoyceDerm, LLC received an FDA Warning Letter for drug-related issues; verify de
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORFEDMulti-topicSep 30, 2026
Primary Source Monitoring: Dauphin County Man Ordered To Forfeit $180,000 For Distributing Misbranded Drugs And Money Laundering
Dauphin County man forfeits $180,000 for distributing misbranded drugs.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORDCScope of PracticeSep 29, 2026
DC B26-0833: Health Occupations and Emergency Medical Services Amendment Act of 2026
DC Bill B26-0833 proposes changes to health occupation regulations.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORUTScope of PracticeSep 25, 2026
UT State Licensing Agency: 2026 Periodic Review: Anesthesiologist Assistants
Utah's periodic review of anesthesiologist assistants may impact med spas.
What to do — members only.Become a member →State Licensing Agencyprimary source ↗ - MONITORFEDAesthetic InjectablesSep 24, 2026
FDA import refusal: Lidocaine (India)
FDA refused entry of lidocaine from Maharashtra, India; confirm violation detail
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Zydus Cadila · Mumbai · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesSep 24, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Germany)
FDA refused entry of OnabotulinumtoxinA from Hassia, Germany.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz Pharmaceuticals GmbH · Frankfurt Am Main · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesSep 24, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
Onabotulinumtoxina from South Korea refused entry by FDA on Sept 24, 2026.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Bio Inc. · Hwaseong · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesSep 23, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refused entry of collagen dermal implants from Sweden; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingFDA: VAISep 23, 2026
FDA inspection citations: Baxter Healthcare Corporation (5 observations)
FDA cites Baxter Healthcare for multiple sterile drug observation violations.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDAesthetic InjectablesSep 22, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry for South Korean collagen dermal implants; effective Sept 22,
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · MAYPHARM · Geumcheon · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesSep 22, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry for collagen dermal implants from South Korea on Sept 22, 2026
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · USKIN COMPANY INC. · Seocho · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesSep 22, 2026
FDA import refusal: Implant, Dermal, for Aesthetic Use in the Hands (South Korea)
FDA refused entry of dermal implants from South Korea; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · SJM COSMETIC CO., LTD · Gimpo-Si, Gyeonggi-Do · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesSep 22, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of collagen dermal implants from South Korea; verify supply ch
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Across Co., Ltd · Chuncheon-si · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDGLP-1 CompoundingSep 22, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (Japan)
Tirzepatide from Osaka, Japan refused entry by FDA; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · MITSUBISHI TANABE PHARMA CORPORATION . · Osaka · drug product · refused as unapproved new drug
- MONITORFEDMulti-topicSep 21, 2026
Primary Source Monitoring: Former Connecticut Resident Guilty of Operating Websites to Illegally Sell Misbranded and Unapproved Drugs
Caution urged due to recent conviction for selling misbranded drugs.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesSep 21, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Italy)
FDA refused entry of collagen implants from Italy; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · IBSA DERMA PRODUCTS · Lodi · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDMulti-topicSep 21, 2026
Primary Source Monitoring: Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate…
Dexmedetomidine HCl recall due to particulate matter presence.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - CRITICALFEDMulti-topicFDA: OAISep 18, 2026
FDA Warning Letter: Empower Clinic Services, LLC (Drugs)
FDA cites Empower Clinic Services for CGMP violations; effective Sept 18, 2026.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORFEDDermal FillersSep 17, 2026
Primary Source Monitoring: Korea Filler Experts - 718706 - 11/03/2025
FDA warns koreafillerexperts.com over unapproved, misbranded injectable botulinum toxin.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesSep 16, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refused entry of ONABOTULINUMTOXINA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Numeco · Unknown · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesSep 16, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry for South Korean dermal collagen implants.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Pharmaresearch · Gangneung-si · plastic-surgery device · refused as misbranding, adulteration
- CRITICALFEDAesthetic DevicesSep 16, 2026
FDA device recall (Class II): Product Name: DermaV Laser System Model/Catalog Number: DermaV Medical laser device that delivers pulsed laser energy a…
FDA recalls DermaV Laser System; check for safety compliance.
What to do — members only.Become a member →FDA Device Recallprimary source ↗ - MONITORFEDAesthetic InjectablesSep 16, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses shipment of collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · MAYPHARM · Geumcheon · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesSep 16, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of South Korean dermal collagen implants.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · QUIVER MEDIC INC. · Yeongdeungpo · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesFDA: VAISep 16, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
FDA refuses entry of OnabotulinumtoxinA from Ireland.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Pharmaceuticals Ireland · Westport · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesSep 16, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refused a shipment of collagen implants from Sweden — avoid gray-market sour
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDGLP-1 CompoundingSep 16, 2026
Primary Source Monitoring: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
FDA updates compounding guidelines as GLP-1 supplies stabilize.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesSep 16, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of South Korean collagen implants for aesthetics.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daehan Nupharm · Hwaseong · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesSep 16, 2026
FDA import refusal: Lidocaine (South Korea)
Lidocaine from South Korea was refused entry by the FDA; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daehan Nupharm · Hwaseong · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAISep 16, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses shipment of dermal collagen from France — verify your sources.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Industrie SAS · Pringy · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesSep 16, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses entry of OnabotulinumtoxinA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Medytox Inc. · Cheongju · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesSep 16, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Vietnam)
FDA refuses ONABOTULINUMTOXINA from Vietnam; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · COMEM NATURAL JSC · Ha Noi · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAISep 16, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA rejects ONABOTULINUMTOXINA shipment from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) · Hwaseong · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesSep 16, 2026
FDA import refusal: Lidocaine (South Korea)
FDA refuses lidocaine shipment from South Korea due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · BIOPHARMA · Seoul · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesSep 16, 2026
FDA import refusal: Daxxify (daxibotulinumtoxinA)-LANM (Vietnam)
FDA blocks import of DaxibotulinumtoxinA-Lanm from Vietnam.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · COMEM NATURAL JSC · Ha Noi · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesSep 15, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses shipment of dermal collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · KORESTETICS · Incheon Yeon · plastic-surgery device · refused as misbranding, unapproved new drug
- MONITORFEDGLP-1 CompoundingSep 15, 2026
Source qualification pending
Consequential guidance is withheld while the exact primary source, scope or named-entity binding is reviewed. This is an unresolved qualification gap, not a finding that the underlying report is false.
Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesSep 15, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Canada)
FDA refuses entry of Canadian dermal collagen shipment.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Prollenium Medical Technologies Inc. · Richmond Hill · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesSep 14, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Vietnam)
FDA refuses entry of collagen implant shipment from Vietnam.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · COMEM NATURAL JSC · Ha Noi · plastic-surgery device · refused as misbranding, adulteration, unapproved new drug
- MONITORFEDAesthetic InjectablesSep 14, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refused entry of a dermal collagen implant from Sweden on Sep 14, 2026.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused as misbranding
- CRITICALFEDMulti-topicFDA: OAISep 14, 2026
FDA Warning Letter: Sca Pharmaceuticals, Inc. (Drugs)
SCA Pharmaceuticals received an FDA Warning Letter; verify your supply sources.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORFEDGLP-1 CompoundingSep 10, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (Japan)
FDA refuses tirzepatide import from Japan; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ELI LILLY JAPAN · Kobe · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesSep 10, 2026
FDA import refusal: Lidocaine (India)
Lidocaine from India refused by FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · SANKALP HEALTHCARE · MAHARASTRA · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesSep 9, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses entry for OnabotulinumtoxinA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Medytox Inc. · Cheongju · drug product · refused as unapproved new drug
- MONITORFEDGLP-1 CompoundingSep 9, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (France)
FDA refuses entry of French semaglutide shipment.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · TANDJIGORA MOHAMED · Aulnay Sous Bois · drug product · refused as misbranding, unapproved new drug
- MONITORFEDGLP-1 CompoundingSep 9, 2026
Primary Source Monitoring: Human Drug Compounding Policies and Rules
FDA’s Human Drug Compounding Policies and Rules index displays content current as of September 9, 2026 and lists its September 4, 2026 guidance on compounding certain starter parenteral nutrition drug products for neonates.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesSep 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Spain)
FDA refused dermal collagen implants from Spain; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · SESDERMA SL · Pucol · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAISep 8, 2026
FDA import refusal: Daxxify (daxibotulinumtoxinA)-LANM
FDA refuses entry of DaxibotulinumtoxinA-Lanm from California.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Revance Therapeutics, Inc · Newark · drug product · refused as misbranding
- MONITORFEDGLP-1 CompoundingFDA: VAISep 8, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (Italy)
FDA refuses tirzepatide from Italy; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Eli Lilly Italia SPA · Sesto Fiorentino · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesSep 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry for collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Bio Plus Co. Ltd · Seongnam · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesSep 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refuses entry of dermal collagen implants from Sweden.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Jonas Lindgren, M.D. · Uppsala · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesSep 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses entry of collagen implants from France - verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · COTE DAZUR PHARMACY · Nice · plastic-surgery device · refused as misbranding
- MONITORFEDGLP-1 CompoundingSep 4, 2026
Source qualification pending
Consequential guidance is withheld while the exact primary source, scope or named-entity binding is reviewed. This is an unresolved qualification gap, not a finding that the underlying report is false.
Primary Source Monitoringprimary source ↗ - MONITORFEDMulti-topicSep 4, 2026
Primary Source Monitoring: Med Spa Owner Sentenced to 46 Months in Prison for Performing Thousands of Counterfeit Botox and Filler Injections
Med spa owner sentenced for using counterfeit Botox and fillers.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDGLP-1 CompoundingSep 3, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (Japan)
FDA refuses tirzepatide entry from Japan; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Eli Lilly Japan K.K.Seishin Laboratories · Nishigun · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesSep 3, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refused entry of collagen injectables from Sweden; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesSep 3, 2026
FDA import refusal: Implant, Dermal, for Aesthetic Use in the Hands (Sweden)
FDA refuses entry of dermal implants from Sweden.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused entry by FDA
- MONITORWAScope of PracticeSep 3, 2026
WA State Health Agency: Registered Nurse (RN) and Licensed Practical Nurse (Lpn) Licensing Requirements
RN and LPN licensing rules in Washington may affect aesthetic practices.
What to do — members only.Become a member →State Health Agencyprimary source ↗ - MONITORFEDAesthetic InjectablesSep 3, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of collagen implants from South Korea—verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · UNKNOWN · UNKNOWN · plastic-surgery device · refused as adulteration
- MONITORFEDAesthetic InjectablesSep 3, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Switzerland)
FDA refuses entry for aesthetic collagen implants from Switzerland.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · PROFESSIONAL DERMA SA · Lugand · plastic-surgery device · refused as adulteration
- MONITORFEDAesthetic InjectablesSep 3, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA blocks shipment of aesthetic collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · S THEPHARM CO · Uiwang-si · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesSep 3, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Austria)
FDA rejects dermal collagen implant from Austria—verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · GALDERMA AUSTRIA GMBH · Vienna · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesSep 1, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refused a dermal collagen implant shipment from Sweden.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused as misbranding
- MONITORFEDPeptidesSep 1, 2026
Primary Source Monitoring: Peak Performance Peptides - 735127 - 08/24/2026
FDA warns about unapproved peptide products; assess your suppliers.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 31, 2026
FDA import refusal: Tirzepatide (Anti-diabetic)
FDA blocks tirzepatide shipment from Indiana; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Eli Lillyand Company · Indianapolis · drug product · refused as unapproved new drug
- MONITORFEDGLP-1 CompoundingAug 31, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (Canada)
FDA refuses semaglutide shipment from Canada; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · NOVO NORDISK · Mississauga · drug product · refused entry by FDA
- CAUTIONWIScope of PracticeAug 31, 2026
Source review pending
This item is withheld pending independent source review.
Review pending — this item is withheld while its source and final wording are independently checked.
State Administrative Registerprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 28, 2026
Primary Source Monitoring: Agency Information Collection Activities; Proposals, Submissions, and Approvals: Registration of Human Drug Compounding Outsourcing Facilities Under …
FDA proposals may impact compounding practices for med spas.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - CAUTIONOHLasers/EnergyAug 26, 2026
OH HB377: Regards use of light-based medical devices for hair removal
Ohio HB 377 sets supervision rules for light-based hair removal.
Review pending — this item’s action instruction is withheld while it is checked against the primary source.
LegiScanprimary source ↗ - MONITORFEDAesthetic InjectablesFDA: VAIAug 26, 2026
FDA import refusal: Lidocaine (China)
FDA refused lidocaine import from Anhui, China; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Planet (Anhui) Pharmaceuticals Co., Ltd · Chuzhou · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesAug 25, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses entry of OnabotulinumtoxinA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · DAEWOONG PHARM CO LTD · Seoul · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesAug 25, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (United Kingdom)
FDA refuses entry of UK collagen dermal implants — confirm violation details.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · MERZ PHARMA · Hemel Hempstead · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesAug 25, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses entry for onabotulinumtoxinA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Medytox Inc. · Cheongju · drug product · refused entry by FDA
- CAUTIONFEDAesthetic DevicesFDA: VAIAug 25, 2026
FDA Warning Letter: Advance-Esthetic LLC (Devices)
FDA says Zemits CrystalFrax Pro, Abigon Pro and Bionexis Lite Pro RF and light body-contouring devices lack required FDA approval or clearance.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORFEDMulti-topicAug 25, 2026
Primary Source Monitoring: Drug Shortages | Additional News and Information
Stay informed about updated drug shortages affecting aesthetics.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesAug 25, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Switzerland)
FDA denies entry of Swiss collagen implants due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Teoxane S.A. · Geneva · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesAug 25, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Switzerland)
Collagen implants from Switzerland refused entry by FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · PROFESSIONAL DERMA SA · Lugand · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesAug 25, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refused entry of collagen implants from Sweden.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesAug 25, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Switzerland)
FDA refuses entry of Swiss collagen implants — beware sourcing risks.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · MATEXLAB SA · Geneva · plastic-surgery device · refused entry by FDA
- MONITORFEDMulti-topicAug 25, 2026
Primary Source Monitoring: Human Drug Compounding Outsourcing Facility Fees
FDA fees for drug compounding could affect your practice costs.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - CAUTIONFEDGLP-1 CompoundingAug 24, 2026
FDA Warning Letter: Peak Performance Peptides (Drugs)
FDA says Peak Performance Peptides' "research use only" semaglutide, retatrutide and other peptides, and the BAC water sold with them, are unapproved.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONFEDGLP-1 CompoundingAug 24, 2026
FDA Warning Letter: Royal Peptides LLC (Drugs)
FDA says Royal Peptides' "research use only" GLP-1s and other peptides are unapproved drugs. Its weight-loss claims, and the bacteriostatic water, "peptide guide" and "peptide calculator" sold alongside them, were FDA's evidence they were meant for injection in people.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONFEDGLP-1 CompoundingAug 24, 2026
FDA Warning Letter: Peptide Partners, LLC (Drugs)
FDA says Peptide Partners' "research use only" GLP-1s and other injectable peptides are unapproved drugs. Health claims on its own product pages were FDA's evidence that they were intended for human use.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORFEDAesthetic InjectablesFDA: VAIAug 23, 2026
FDA import refusal: Lidocaine (Anesthetic) (Canada)
Lidocaine from Canada refused entry by FDA – confirm violation details.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · HK Kolmar Canada, Inc. · Barrie · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesAug 22, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refused entry for collagen implants from France; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · CHRISTIAN DIOR · Saint-Jean-De-Braye · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDMulti-topicAug 21, 2026
Primary Source Monitoring: Compounding and the FDA: Questions and Answers
FDA’s Compounding and the FDA: Questions and Answers page displays content current as of September 16, 2025 and states that compounded drugs are not FDA-approved.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesAug 21, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses entry of OnabotulinumtoxinA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Huons Global Co. Ltd · Jecheon-Si · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesAug 21, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA blocks entry of onabotulinumtoxinA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Medytox Co. Ltd. · Heungdeok-Gu · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesAug 21, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses aesthetic collagen implants from South Korea; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · BioPlus Co.,Ltd. · Seongnam · plastic-surgery device · refused as misbranding
- MONITORFEDMulti-topicAug 21, 2026
Primary Source Monitoring: Compounding Information for States
FDA’s Compounding Information for States page displays content current as of August 28, 2026.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesAug 20, 2026
FDA import refusal: Acid, Hyaluronic, Intraarticular (Ireland)
FDA refused hyaluronic acid import from Ireland; confirm violation details.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · MYLAN INTERNATIONAL · Galway · medical device · refused as misbranding
- MONITORFEDGLP-1 CompoundingAug 19, 2026
FDA recall (Class II): Semaglutide 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, Apollo care, 380…
FDA recalls semaglutide 12.5mg due to contamination risks.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 19, 2026
FDA recall (Class II): Semaglutide 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Onl…
Recall of compounded semaglutide due to contamination reported.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 19, 2026
FDA recall (Class II): Semaglutide 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injectio…
FDA recalls semaglutide 7.5mg due to particulate contamination.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 19, 2026
FDA recall (Class II): Semaglutide 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, Apollo care, 3801 …
Recall of contaminated semaglutide vials.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 19, 2026
FDA recall (Class II): Semaglutide 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injecti…
Apollo Care recalls semaglutide for harmful particulate matter.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 19, 2026
FDA recall (Class II): Semaglutide 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection On…
FDA recalls semaglutide due to contamination risks.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 19, 2026
FDA recall (Class II): Semaglutide 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection On…
Important recall: Check your inventory for affected semaglutide vials.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 19, 2026
FDA recall (Class II): Semaglutide 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, Apollo care, 380…
FDA recalls semaglutide from Apollo Care due to contamination.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 19, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (Japan)
FDA refuses tirzepatide entry from Japan.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · MITSUBISHI TANABE PHARMA CORPORATION . · Osaka · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesAug 19, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses entry of dermal collagen implants from France.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · LABORATOIRES VIVACY · Paris-L'Hopital · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesAug 19, 2026
FDA import refusal: Hyaluronidase (France)
FDA rejects hyaluronidase from France; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · IBSA Pharma SAS · Antibes · drug product · refused as misbranding, unapproved new drug
- MONITORFEDGLP-1 CompoundingAug 19, 2026
FDA recall (Class II): Semaglutide 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, Apollo care, 380…
FDA recalls semaglutide vials due to contamination concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFEDGLP-1 CompoundingAug 19, 2026
Source qualification pending
Consequential guidance is withheld while the exact primary source, scope or named-entity binding is reviewed. This is an unresolved qualification gap, not a finding that the underlying report is false.
FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingAug 19, 2026
FDA recall (Class II): Semaglutide 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, Apollo care, …
FDA recalls semaglutide due to contamination risks.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDAesthetic InjectablesAug 19, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refused an injectable collagen shipment from Sweden; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIAug 19, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses ONABOTULINUMTOXINA from South Korea - verify your sources.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) · Hwaseong · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAIAug 19, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use
FDA refused entry of collagen dermal implants from Wisconsin.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz North America, Inc. · Franksville · plastic-surgery device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingFDA: VAIAug 18, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (Denmark)
Semaglutide shipment from Denmark refused by FDA; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Novo Nordisk A/S · Bagsvard · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAIAug 18, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
FDA refuses entry to OnabotulinumtoxinA from Ireland — verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Pharmaceuticals Ireland · Westport · drug product · refused as misbranding, unapproved new drug · FDA lab-analyzed
- MONITORFEDAesthetic InjectablesAug 18, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
OnabotulinumtoxinA shipment refused by FDA; check your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Medytox Inc. · Cheongju · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesAug 18, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA rejects collagen implant shipment from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q MED AB, SEMINARIEGATAN 21 · Gangwon · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDGLP-1 CompoundingAug 17, 2026
Primary Source Monitoring: Illinois Man Charged With Scheme To Impersonate Doctors And Make False Statements To Obtain GLP-1 Medications
Fraud case underlines risks in GLP-1 medication practices.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesAug 14, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
Imports of collagen implants from South Korea denied by FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Koru Pharmaceuticals Co., Ltd · Gangnam · plastic-surgery device · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesAug 14, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refused onabotulinumtoxinA from South Korea; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Pharmaceutical · Hwasung Gun · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesAug 14, 2026
FDA import refusal: Lidocaine (Anesthetic) (South Korea)
FDA refuses lidocaine shipment from South Korea; supplier verification needed.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · GDK Cosmetics Co., Ltd. · Namdong · drug product · refused as adulteration
- MONITORFEDAesthetic InjectablesAug 14, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refused entry of a collagen implant shipment from France.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Galderma Internati · La Defence Ce · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesFDA: VAIAug 14, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Switzerland)
FDA refuses entry of collagen products from Switzerland; verify sources.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · IBSA Institut Biochimique SA · Pazzallo · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesAug 14, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA rejects collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Reanzen Co., Ltd · Pyeongtaek · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesAug 14, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses entry for dermal collagen implants from France.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · LABORTORIES FILLMED · Paris-L'Hopital · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesFDA: VAIAug 14, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refused entry of OnabotulinumtoxinA from South Korea—avoid gray markets.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) · Hwaseong · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesAug 14, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Japan)
FDA rejects collagen implants from Japan; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · TSK LABORATORY INTERNATIONAL, JAPAN · Tochigi · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesAug 14, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of dermal collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Genoss Co., Ltd · Suwon · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesAug 14, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Italy)
FDA refuses dermal collagen implant shipment from Italy.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · LICOFARMA SRL · Galatina · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesAug 14, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused a shipment of South Korean collagen implants.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Across Co., Ltd · Chuncheon-si · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDGLP-1 CompoundingFDA: VAIAug 14, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (Denmark)
Semaglutide shipment from Denmark refused by FDA; verify your supplies.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Novo Nordisk A/S · Bagsvard · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesAug 14, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of collagen implant from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Janytree Inc. · Geumcheon · plastic-surgery device · refused as adulteration, misbranding
- MONITORFEDAesthetic InjectablesAug 14, 2026
FDA import refusal: Acid, Hyaluronic, Intraarticular (South Korea)
FDA refused entry of a hyaluronic acid shipment from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Across Co., Ltd · Chuncheon-si · medical device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingAug 14, 2026
FDA import refusal: Tirzepatide (Anti-diabetic)
Tirzepatide from India refused entry by FDA; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Eli Lilly & Company · Indianapolis · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAIAug 14, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (United Kingdom)
FDA refused onabotulinumtoxinA from Clwyd, UK; avoid overseas sources.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Ipsen BioPharm Ltd · Wrexham · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesAug 14, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses entry of onabotulinumtoxinA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Medytox Inc. · Cheongju · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAIAug 14, 2026
FDA import refusal: Lidocaine Hcl (Anesthetic) (France)
FDA refuses entry of Lidocaine HCl from France - verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Septodont Ou Septodont SAS Ou Specialites Septodont · St Maur Des Fosses · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesAug 13, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Italy)
FDA refuses collagen implant from Italy.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · IBSA Farmaceutici Italia Srl · Lodi · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesAug 13, 2026
FDA import refusal: Dermal Cooling PACK/VACUUM/MASSAGER (China)
FDA refuses entry of dermal products from China; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · SHENZHEN JINSHANG ELECTRONIC TEC · Shenzhen · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesAug 13, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
Dermal collagen implants from South Korea refused entry by the FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Feel Tech Co., Ltd · Jeonbuk · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesFDA: VAIAug 13, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Germany)
FDA refused entry of OnabotulinumtoxinA from Germany; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz Pharma Gmbh & Co. KGaA · Reinheim · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesAug 13, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use
FDA refuses entry of collagen dermal implants from Missouri.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ELTA MD · Carrolton · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesFDA: VAIAug 13, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refused entry of OnabotulinumtoxinA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) · Hwaseong · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesAug 13, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refused collagen implants from Sweden; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesAug 13, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
US FDA refused entry of dermal collagen from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Across Co., Ltd · Chuncheon-si · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesAug 13, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of dermal collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · BioPlus Co.,Ltd. · Seongnam · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesAug 13, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA denies entry of a collagen implant from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · PHARMARESEARCH CO., LTD. · Seongnam · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesAug 13, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
Import of collagen implants from South Korea refused by FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Medytox Inc. · Cheongju · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesAug 13, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry for collagen dermal implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Forest Hills Lab Korea Co Ltd · Gyeonggi-do · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesFDA: VAIAug 13, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
FDA blocks ONABOTULINUMTOXINA from Co. MAYO, Ireland.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Pharmaceuticals Ireland · Westport · drug product · refused as misbranding, unapproved new drug · FDA lab-analyzed
- MONITORFEDGLP-1 CompoundingFDA: VAIAug 13, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (Denmark)
Semaglutide shipment from Denmark refused by FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Novo Nordisk A/S · Bagsvard · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAIAug 13, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Canada)
FDA refused entry of Canadian collagen implants; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Prollenium Medical Technologies Inc. · Aurora · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesAug 13, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses shipment of collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · DONGBANG MEDICAL CO.,LTD · Yongin-Si · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesAug 13, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
OnabotulinumtoxinA from South Korea refused entry by FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · DAEWOONG PHARM CO LTD · Seoul · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesFDA: VAIAug 13, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refused a shipment of collagen implants from France.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Industrie SAS · Pringy · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesAug 12, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Germany)
FDA refuses entry of OnabotulinumtoxinA from Hassia, Germany.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz Pharmaceuticals GmbH · Frankfurt Am Main · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIAug 12, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (United Kingdom)
FDA refuses import of onabotulinumtoxinA from UK.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Ipsen BioPharm Ltd · Wrexham · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesAug 12, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Switzerland)
FDA refuses entry of Swiss collagen implants; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Teoxane S.A. · Geneva · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesAug 12, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses shipment of collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Dongbang Medical Co. Ltd · Dongbangbaekjungang-ro · plastic-surgery device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingFDA: VAIAug 12, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (Denmark)
FDA refused entry for semaglutide from Denmark.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Novo Nordisk A/S · Bagsvard · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAIAug 12, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Canada)
FDA refuses collagen implant shipment from Canada; check your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Prollenium Medical Technologies Inc. · Aurora · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesAug 12, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Vietnam)
FDA refused entry for Vietnamese collagen implants; verify your sources.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · NGUYEN VIET ANH - CCCD#035094002294 · Hanoi Center · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesAug 12, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refused collagen implant shipment from Sweden; verify your supplier.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingFDA: OAIAug 12, 2026
FDA inspection citations: Steril-Gene Life Sciences Private Ltd (13 observations)
FDA inspection cited Steril-Gene Life Sciences for multiple quality violations.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDAesthetic InjectablesAug 12, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Vietnam)
FDA denied entry of ONABOTULINUMTOXINA from Vietnam due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · NGUYEN VIET ANH - CCCD#035094002294 · Hanoi Center · drug product · refused entry by FDA
- MONITORFEDPeptidesAug 12, 2026
Source qualification pending
Consequential guidance is withheld while the exact primary source, scope or named-entity binding is reviewed. This is an unresolved qualification gap, not a finding that the underlying report is false.
Primary Source Monitoringprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIAug 11, 2026
FDA inspection citations: Galentic Pharma (India) Pvt. Ltd (3 observations)
FDA inspection cites Galentic Pharma for sterility and validation issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDAesthetic InjectablesFDA: VAIAug 11, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry of collagen implants from South Korea—check your sources.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · CG Bio Co., Ltd. · Hwaseong · plastic-surgery device · refused as adulteration, misbranding
- MONITORFEDAesthetic InjectablesAug 10, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses collagen implant shipment from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Across Co., Ltd · Chuncheon-si · plastic-surgery device · refused entry by FDA
- MONITORWIMulti-topicAug 10, 2026
WI State Administrative Register: Emergency Rules Filed with Legislative Reference Bureau - 2026-08-10
Emergency rules may impact licensure practices in Wisconsin.
What to do — members only.Become a member →State Administrative Registerprimary source ↗ - MONITORFEDAesthetic InjectablesFDA: VAIAug 10, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refused entry of OnabotulinumtoxinA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Hugel Inc. · Chuncheon · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIAug 10, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses entry of Onabotulinumtoxina from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) · Hwaseong · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesAug 7, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA rejects dermal collagen implants from South Korea; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Medytox Inc. · Cheongju · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIAug 7, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
FDA refused OnabotulinumtoxinA shipment.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Pharmaceuticals Ireland · Westport · drug product · refused entry by FDA · FDA lab-analyzed
- MONITORFEDAesthetic InjectablesAug 7, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refuses entry for collagen implants from Sweden.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused entry by FDA
- CAUTIONILMulti-topicAug 7, 2026
IL HB5000: Health Facilities Planning
Ownership rules for health care facilities in Illinois affect med spas.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDAesthetic InjectablesAug 6, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA denies entry of foreign collagen implants for aesthetics.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Across Co., Ltd · Chuncheon-si · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesAug 4, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
Collagen implants from France denied entry to the US by FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · LABORTORIES FILLMED · Paris-L'Hopital · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesFDA: VAIAug 4, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
OnabotulinumtoxinA from Ireland refused entry to the US.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Pharmaceuticals Ireland · Westport · drug product · refused as unapproved new drug · FDA lab-analyzed
- MONITORWIMulti-topicAug 3, 2026
Source review pending
This item is withheld pending independent source review.
Review pending — this item is withheld while its source and final wording are independently checked.
State Administrative Registerprimary source ↗ - MONITORFEDAesthetic InjectablesAug 3, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of dermal collagen imports from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · SEORIN COMPANY CO LTD · Chuncheon · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesAug 3, 2026
FDA import refusal: Solution, Sodium Hyaluronate (South Korea)
FDA refuses entry for sodium hyaluronate from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Dongkook Pharmaceutical Co., Ltd. · Seoul · medical device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesFDA: VAIAug 3, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
FDA refuses entry of injectable product ONABOTULINUMTOXINA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Pharmaceuticals Ireland · Westport · drug product · refused entry by FDA · FDA lab-analyzed
- MONITORFEDAesthetic InjectablesAug 3, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refused shipment of OnabotulinumtoxinA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Medytox Inc. · Cheongju · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAIJul 31, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses OnabotulinumtoxinA shipment from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) · Hwaseong · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 31, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refuses entry of dermal collagen implants from Sweden.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 31, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry for collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · WEDERM · Seoul · plastic-surgery device · refused as misbranding
- MONITORFEDMulti-topicJul 31, 2026
Primary Source Monitoring: Illinois Man and Indiana Woman Sentenced Respectively to 70 Months and 16 Months in Prison For Selling Unapproved Drugs in Interstate Commerce
Sentencing for selling unapproved drugs serves as a warning.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesFDA: VAIJul 31, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
FDA refuses entry of onabotulinumtoxinA from Ireland.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Pharmaceuticals Ireland · Westport · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 31, 2026
FDA import refusal: Lidocaine (Guatemala)
Lidocaine from Guatemala refused entry by FDA; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · SELECTPHAMA · Mixco · drug product · refused as unapproved new drug
- MONITORFEDGLP-1 CompoundingJul 31, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (Vietnam)
FDA refuses entry of Tirzepatide from Vietnam; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · NGUYEN VIET ANH - CCCD#035094002294 · Hanoi Center · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAIJul 31, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use
FDA refuses entry of collagen implants for aesthetic use.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Revance Therapeutics, Inc · Newark · plastic-surgery device · refused as misbranding
- MONITORFEDGLP-1 CompoundingJul 30, 2026
FDA / Federal Register Notice: Outsourcing Facility Fee Rates for Fiscal Year 2027
FDA announces FY2027 fees for registered outsourcing facilities.
What to do — members only.Become a member →Federal Registerprimary source ↗ - MONITORFEDAesthetic InjectablesJul 29, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Pharmaresearch · Gangneung-si · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIJul 27, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses import of OnabotulinumtoxinA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Hugel Inc. · Chuncheon · drug product · refused as misbranding
- MONITORFEDGLP-1 CompoundingJul 27, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (Japan)
FDA blocks tirzepatide shipment from Japan.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Eli Lilly Japan K.K.Seishin Laboratories · Nishigun · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAIJul 27, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses entry of injectable product from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) · Hwaseong · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 27, 2026
FDA import refusal: Lidocaine (South Korea)
FDA refuses entry of lidocaine from South Korea; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Vivozon Pharmaceutical · Hwaseong · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 27, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of dermal collagen implant from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · BioPlus Co.,Ltd. · Seongnam · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 27, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refused entry for a collagen implant from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ACROSS CO LTD · Chuncheon-Si · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 27, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses entry of ONABOTULINUMTOXINA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · PharmaResearch BIO Co., Ltd. · Gangreung · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 27, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses entry of ONABOTULINUMTOXINA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Meditox Co. · Heungdeok-gu · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 25, 2026
FDA import refusal: Acid, Hyaluronic, Intraarticular (Sweden)
FDA refuses entry of hyaluronic acid from Sweden for unknown violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-MED AB · Sweden · medical device · refused as misbranding, adulteration
- MONITORFEDGLP-1 CompoundingJul 24, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (China)
FDA rejects tirzepatide shipment from China due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · CHONGUHAN MEDICAL TECHNOLOGIES · Guangzhou · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA blocks botulinum toxin from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Meditox Co. Ltd. · Unknown · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of aesthetic collagen implant from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · HNG Co., Ltd. · Seocho · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Vietnam)
FDA refuses entry of OnabotulinumtoxinA from Vietnam; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · TRAN THI THU HIEN · Ha Noi City · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA rejects botulinum toxin import from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · PharmaResearch BIO Co., Ltd. · Gangreung · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry for dermal collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Pharmaresearch · Gangneung-si · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Austria)
FDA refuses entry of collagen implants from Austria; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · CROMA-PHARMA GMBH · Leobendorf · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses shipment of aesthetic collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · SEORIN COMPANY CO LTD · Chuncheon · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA blocks import of dermal collagen from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Forest Hills Lab Korea Co Ltd · Gyeonggi-do · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refused entry of collagen implants from Sweden; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Switzerland)
FDA refuses entry of dermal collagen implant from Switzerland.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ANTEIS SA · Plan-les-Ouates · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Triamcinolone Acetonide (Glucocorticoid) (Guatemala)
FDA refuses Guatemala-sourced triamcinolone acetonide shipment.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · LABORATORIO PIERSAN S.A. · Cdad · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Lidocaine (China)
FDA refuses lidocaine shipment from China due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Shaanxi Bieyouth Biotech Co.,Ltd · Xian · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses entry of French collagen implant for aesthetics.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ALLERGAN · Annecy · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Switzerland)
FDA refuses entry of collagen dermal implants from Switzerland.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Teoxane S.A. · Geneva · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesFDA: VAIJul 24, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (United Kingdom)
FDA refuses ONABOTULINUMTOXINA import; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Ipsen BioPharm Ltd · Wrexham · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAIJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses shipment of collagen implant from France.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Industrie SAS · Pringy · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesFDA: VAIJul 24, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Germany)
FDA refuses entry for OnabotulinumtoxinA from Germany.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz Pharma Gmbh & Co. KGaA · Reinheim · drug product · refused as misbranding, unapproved new drug
- MONITORFEDGLP-1 CompoundingFDA: VAIJul 24, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (Denmark)
FDA refused entry of semaglutide from Denmark.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Novo Nordisk A/S · Bagsvard · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAIJul 24, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use
Collagen implant shipment refused by FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz North America, Inc. · Franksville · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 22, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Vietnam)
FDA refuses entry of dermal collagen implant from Vietnam.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · TRAN THI THU HIEN · Ha Noi City · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDGLP-1 CompoundingJul 22, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (India)
FDA rejects tirzepatide import from India.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ELI LILLY AND COMPANY PVT LTD · Bhiwandi · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJul 21, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Vietnam)
FDA rejects injectable collagen from Vietnam due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · CHIAKI TRADING JSC · Hanoi City · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesFDA: OAIJul 21, 2026
FDA import refusal: Lidocaine (Belgium)
FDA refuses entry of lidocaine from Belgium.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Laboratoria Qualiphar NV · Bornem · drug product · refused as adulteration
- MONITORFEDGLP-1 CompoundingFDA: VAIJul 21, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (Denmark)
FDA rejects semaglutide shipment from Denmark; verify supplier sources.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Novo Nordisk A/S · Bagsvard · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJul 17, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Colombia)
FDA refuses entry of Colombian dermal collagen implant.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · GALDERMA DE COLOMBIA SA · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDMulti-topicJul 17, 2026
Source qualification pending
Consequential guidance is withheld while the exact primary source, scope or named-entity binding is reviewed. This is an unresolved qualification gap, not a finding that the underlying report is false.
Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesJul 16, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refuses entry of Swedish collagen implant for aesthetics.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIJul 16, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
FDA refuses entry of OnabotulinumtoxinA from Ireland.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Pharmaceuticals Ireland · Westport · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 14, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
Important: FDA refuses dermal implant shipment from Sweden.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · MARELI MEDICAL AB · Malmo · plastic-surgery device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingJul 13, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (United Kingdom)
FDA refuses entry of injectable Semaglutide from the UK.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ASIAN SUITS ONLINE LIMITED · Leicester · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesJul 11, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses entry of collagen implants from France.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ALLERGAN · Annecy · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 11, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry for collagen dermal implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · SEORIN COMPANY CO LTD · Chuncheon · plastic-surgery device · refused as misbranding
- MONITORFEDGLP-1 CompoundingJul 10, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (Canada)
FDA refuses semaglutide shipment from Canada; avoid gray-market sources.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · NOVO NORDISK · Mississauga · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJul 10, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refuses entry of a dermal collagen implant from Sweden.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 10, 2026
FDA import refusal: Botox (onabotulinumtoxinA)
FDA refuses entry of OnabotulinumtoxinA from Illinois due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · AbbVie Inc. · North Chicago · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesFDA: VAIJul 10, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses entry of collagen implant from France; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Industrie SAS · Pringy · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 10, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (India)
FDA rejects ONABOTULINUMTOXINA from India.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · HIMANI BIOSCIENCES · Solan · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJul 10, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Italy)
FDA refuses entry for collagen implants from Italy; check your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · IBSA Farmaceutici Italia Srl · Lodi · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 10, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Italy)
FDA refuses entry of Italian collagen implants.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Mariior · Marignano · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesFDA: VAIJul 10, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses ONABOTULINUMTOXINA from South Korea; verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) · Hwaseong · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesJul 10, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Germany)
Injectable collagen implants from Germany denied entry by FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz Pharmaceuticals GmbH · Frankfurt Am Main · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 9, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of South Korean collagen dermal implants.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · BNC Global · Incheon · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Brazil)
FDA refuses Brazilian collagen implant shipment.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Pharmaesthetics do Brasil Industria de Medicamentos LTDA · Zielonka · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refuses entry of collagen implants from Sweden; heed sourcing warnings.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIJul 8, 2026
FDA import refusal: Daxxify (daxibotulinumtoxinA)-LANM
FDA refuses entry for DAXIBOTULINUMTOXINA-LANM; avoid unverified sources.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Revance Therapeutics, Inc · Newark · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 8, 2026
FDA import refusal: Implant, Dermal, for Aesthetic Use in the Hands (Sweden)
FDA refuses dermal implant entry from Sweden.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Q-Med AB · Uppsala · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 8, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses entry of overseas collagen implant.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Sinclair France SAS · Dardilly · plastic-surgery device · refused entry by FDA
- CRITICALFEDMulti-topicFDA: OAIJul 8, 2026
FDA Warning Letter: Spa De Soleil, Inc. (Drugs)
Water Spa De Soleil uses to make over-the-counter topical products failed testing 51 times from 2024 to 2025. FDA had cited similar problems in 2021.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORFEDAesthetic InjectablesJul 7, 2026
FDA import refusal: Solution, Sodium Hyaluronate (Paraguay)
Product shipment from Paraguay refused by FDA; heed sourcing warnings.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · FABIANO DA SILVA MATOS · Ciudad Del Este · medical device · refused as misbranding
- MONITORFEDGLP-1 CompoundingJul 7, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (United Kingdom)
FDA refuses entry of TIRZEPATIDE from the UK; verify suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ARAMEX- TRANSIT · Slough · drug product · refused as adulteration
- MONITORFEDAesthetic InjectablesFDA: VAIJul 6, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use
FDA refused entry of dermal collagen implants on July 6, 2026.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz North America, Inc. · Franksville · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 6, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses entry for collagen implants from France.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan · Pringy 74370 Annecy · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 6, 2026
FDA import refusal: Lidocaine (Sweden)
FDA refuses entry of lidocaine shipment from Sweden.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · MARELI MEDICAL AB · Malmo · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 5, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of injectable collagen from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · SEORIN COMPANY CO LTD · Chuncheon · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesJul 2, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Vietnam)
FDA refuses shipment of collagen implant from Vietnam.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · CHIAKI TRADING JSC · Hanoi City · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 2, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Vietnam)
FDA refuses ONABOTULINUMTOXINA shipment from Vietnam.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · TRAN THI THU HIEN · Ha Noi City · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 2, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses ONABOTULINUMTOXINA from South Korea; review your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Medytox Inc. · Cheongju · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJul 2, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA rejects collagen implants from South Korea; check your sources.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · LG Chemical LTD. · Seoul · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesFDA: VAIJul 2, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (United Kingdom)
FDA bars entry of ONABOTULINUMTOXINA from the UK.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Ipsen BioPharm Ltd · Wrexham · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesJul 2, 2026
FDA import refusal: Lidocaine (India)
FDA refuses entry of lidocaine from India.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ARISTO PHARMACEUTICALS · Mumbai · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJul 2, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA denies entry to a dermal collagen implant from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · BioPlus Co.,Ltd. · Seongnam · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 2, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Switzerland)
Imported collagen implants from Switzerland were refused by the FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · GALDERMA LABORATORIES · Lausanne · plastic-surgery device · refused as misbranding, adulteration
- MONITORFEDAesthetic InjectablesJul 2, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses OnabotulinumtoxinA shipment from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Medytox Inc. · Cheongju · drug product · refused as misbranding, unapproved new drug
- MONITORFEDMulti-topicJul 1, 2026
Primary Source Monitoring: Massachusetts Couple Sentenced to Prison for Importing Misbranded Drugs From China and Selling Them to Customers in U.S. for Performance Enhancing Pu…
DOJ reported on July 1, 2026 that a Massachusetts couple was sentenced for importing misbranded performance-enhancing drugs from China and selling them in the United States.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIJun 30, 2026
FDA inspection citations: OneSource Specialty Pharma Limited (1 observation)
FDA inspection cites OneSource Specialty Pharma for sterility issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIJun 30, 2026
FDA inspection citations: Meridian Medical Technologies, LLC a Subsidiary of Kindeva Drug Delivery, L.P. (7 observations)
FDA inspection found quality control issues at Meridian Medical Technologies.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDAesthetic InjectablesJun 30, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Vietnam)
FDA refuses entry of OnabotulinumtoxinA from Vietnam.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · HASAKI BEAUTY & CLINIC JSC · Hanoi City · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesFDA: VAIJun 30, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (United Kingdom)
FDA refuses ONABOTULINUMTOXINA from overseas; verify your supplier.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Ipsen BioPharm Ltd · Wrexham · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJun 30, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Sweden)
FDA refuses entry of collagen implant from Sweden—stay cautious.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · MARELI MEDICAL AB · Malmo · plastic-surgery device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingJun 30, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (China)
FDA refuses entry of semaglutide from China.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Hybio Pharmaceutical Co., Ltd. · Shenzhen · drug product · refused as misbranding
- MONITORFEDGLP-1 CompoundingJun 29, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (India)
FDA refuses entry of semaglutide from India.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · NOVO NORDISK INDIA PRIVATE LIMIT · Bangalore · drug product · refused as unapproved new drug
- MONITORFEDAesthetic InjectablesJun 29, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
Shipment of collagen implants from South Korea refused by FDA.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Jemate · Gyeonggi-do · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesJun 29, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Germany)
FDA refuses entry of German botulinum toxin.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Merz Pharmaceuticals GmbH · Frankfurt Am Main · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJun 29, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Vietnam)
FDA blocks vital aesthetic product from Vietnam due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · CHIAKI TRADING JSC · Hanoi City · plastic-surgery device · refused as adulteration
- MONITORFEDAesthetic InjectablesFDA: OAIJun 29, 2026
FDA import refusal: Lidocaine Hcl (Anesthetic) (India)
FDA refuses entry of Lidocaine HCl from India; stay cautious.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Mahendra Chemicals · Ahmedabad · drug product · refused as adulteration
- MONITORFEDAesthetic InjectablesFDA: VAIJun 29, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (France)
FDA refuses entry of French collagen implant due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Industrie SAS · Pringy · plastic-surgery device · refused as misbranding
- MONITORFEDAesthetic InjectablesJun 29, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA blocks import of a dermal collagen implant from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · LG Chem., Ltd. · Iksan · plastic-surgery device · refused as misbranding
- MONITORFEDMulti-topicJun 29, 2026
Source qualification pending
Consequential guidance is withheld while the exact primary source, scope or named-entity binding is reviewed. This is an unresolved qualification gap, not a finding that the underlying report is false.
Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesFDA: VAIJun 29, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
FDA refuses ONABOTULINUMTOXINA entry from Ireland — verify your suppliers.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Allergan Pharmaceuticals Ireland · Westport · drug product · refused entry by FDA
- MONITORFEDAesthetic InjectablesJun 29, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Turkey)
FDA refuses entry of OnabotulinumtoxinA from Turkey.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · ALLERGAN ILACLARI TICARET A.S. · Sariyer · drug product · refused as misbranding, unapproved new drug
- MONITORFEDGLP-1 CompoundingFDA: OAIJun 26, 2026
FDA inspection citations: S.s.s. Company (international) (7 observations)
FDA inspection cites S.s.s. Company for quality and sterility issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDAesthetic InjectablesFDA: VAIJun 26, 2026
FDA import refusal: Lidocaine (China)
FDA refuses lidocaine shipment from China due to violations.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Planet (Anhui) Pharmaceuticals Co., Ltd · Chuzhou · drug product · refused as misbranding
- MONITORFEDGLP-1 CompoundingJun 26, 2026
FDA / Federal Register Notice: List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Extension of Comment Period
FDA extends comment period on GLP-1 compounding decisions.
What to do — members only.Become a member →Federal Registerprimary source ↗ - MONITORFEDAesthetic InjectablesJun 26, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of collagen implants from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · BNC INTERNATIONAL · Incheon · plastic-surgery device · refused entry by FDA
- MONITORFEDAesthetic InjectablesJun 26, 2026
FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
FDA refuses entry of foreign dermal implant; stay vigilant.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · HUGEL CO LTD · Gangnam · plastic-surgery device · refused entry by FDA
- MONITORFEDGLP-1 CompoundingJun 26, 2026
FDA import refusal: Semaglutide (Anti-diabetic) (India)
FDA refuses entry of Semaglutide from India.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · AULI KRUPA · Mumbai · drug product · refused as unapproved new drug
- MONITORFEDGLP-1 CompoundingFDA: VAIJun 26, 2026
FDA inspection citations: Hetero Labs Ltd. Unit VI (6 observations)
FDA inspections cited Hetero Labs for several quality control issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - CAUTIONALMulti-topicJun 25, 2026
AL Primary Source Monitoring: Proposed Rule Changes
Stay informed about proposed rule changes in Alabama.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDAesthetic InjectablesJun 24, 2026
FDA import refusal: Triamcinolone (Glucocorticoid) (Guatemala)
FDA rejects triamcinolone shipment from Guatemala.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Infasa · Mixco · drug product · refused as misbranding, unapproved new drug
- MONITORFEDAesthetic InjectablesJun 24, 2026
FDA import refusal: Lidocaine Hcl (Anesthetic) (South Korea)
FDA refuses shipment of Lidocaine HCL from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Huons Co., Ltd. · Jecheon · drug product · refused as adulteration
- MONITORFEDGLP-1 CompoundingJun 23, 2026
FDA import refusal: Tirzepatide (Anti-diabetic) (Bangladesh)
FDA refuses TIRZEPATIDE import from Bangladesh; details pending.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Drug Internatinal Gazipur Bangladesh · Dhaka · drug product · refused as misbranding
- MONITORFEDAesthetic InjectablesFDA: VAIJun 23, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (South Korea)
FDA refuses entry of ONABOTULINUMTOXINA from South Korea.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Hugel Inc. · Chuncheon · drug product · refused entry by FDA
- MONITORFEDGLP-1 CompoundingFDA: OAIJun 23, 2026
FDA inspection citations: Scinopharm Taiwan, Ltd. (7 observations)
FDA cited Scinopharm Taiwan for issues impacting product quality; review sourcin
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - CAUTIONFEDMulti-topicJun 23, 2026
FDA Warning Letter: ketaminelab.org (Drugs)
FDA says buyketaminepowderonline.com (formerly ketaminelab.org) sells unapproved, misbranded ketamine powder online.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIJun 22, 2026
FDA import refusal: Semaglutide (Anti-diabetic)
FDA refused entry of a semaglutide shipment due to violation.
What to do — members only.Become a member →FDA Import RefusalFDA Import Refusals database ↗FDA record · Novo Nordisk Inc. · Plainsboro · drug product · refused as unapproved new drug
- CAUTIONFEDGLP-1 CompoundingJun 17, 2026
Source qualification pending
Consequential guidance is withheld while the exact primary source, scope or named-entity binding is reviewed. This is an unresolved qualification gap, not a finding that the underlying report is false.
FDA Warning Letterprimary source ↗ - CAUTIONFEDGLP-1 CompoundingJun 17, 2026
Source qualification pending
Consequential guidance is withheld while the exact primary source, scope or named-entity binding is reviewed. This is an unresolved qualification gap, not a finding that the underlying report is false.
FDA Warning Letterprimary source ↗ - CAUTIONFEDMulti-topicJun 17, 2026
FDA Warning Letter: Herbal Dermals LLC Fz (Drugs)
FDA says Gotucream, sold online as a balanitis treatment cream, is an unapproved new drug.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONFEDPeptidesJun 17, 2026
FDA Warning Letter: Wholesale Peptide (Drugs)
FDA says Wholesale Peptide's injectable "Prostamax" and gonadorelin are unapproved new drugs.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONFEDGLP-1 CompoundingJun 17, 2026
Source qualification pending
Consequential guidance is withheld while the exact primary source, scope or named-entity binding is reviewed. This is an unresolved qualification gap, not a finding that the underlying report is false.
FDA Warning Letterprimary source ↗ - CAUTIONFEDMarketing & AdvertisingJun 12, 2026
FTC Files Contempt Motion Against Amare Global and Three Individuals Over Unsubstantiated Health Claims
FTC targets deceptive health claims affecting aesthetic practices.
What to do — members only.Become a member →FTC Enforcementprimary source ↗ - CAUTIONFEDGLP-1 CompoundingJun 11, 2026
FDA shortage: Liraglutide Injection (Injection) — Currently in Shortage
Liraglutide is on the FDA drug shortage list as of Oct 14, 2026.
Review pending — this item’s source changed; the summary below is being re-checked.
FDA Drug Shortagesprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIJun 9, 2026
FDA inspection citations: Parnell Manufacturing Pty, Ltd. (5 observations)
FDA cites Parnell Manufacturing for serious sterile product observations.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIJun 9, 2026
FDA inspection citations: Woodstock Sterile Solutions Inc (5 observations)
FDA citations at Woodstock Sterile Solutions may impact med spas.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITOROHScope of PracticeJun 9, 2026
OH HB963: Revise the law governing the practice of physician assistants
Changes to PAs' practice could affect med spa operations.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORGAMulti-topicJun 5, 2026
GA State Medical Board: Gcmb Statement Regarding: IV Hydration/Therapy Position Statement | June 5, 2026
Georgia issues a position statement on IV hydration therapy.
What to do — members only.Become a member →State Medical Boardprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIJun 5, 2026
FDA inspection citations: Pillar5 Pharma Inc. (4 observations)
FDA cites Pillar5 Pharma for sterile production issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - CAUTIONCAGLP-1 CompoundingMay 27, 2026
CA SB1089: Preventive Treatment Health Care Act.
California SB 1089 enables partnerships to improve access to GLP-1 medications.
What to do — members only.Become a member →LegiScanprimary source ↗ - CRITICALFEDGLP-1 CompoundingMay 27, 2026
Source qualification pending
Consequential guidance is withheld while the exact primary source, scope or named-entity binding is reviewed. This is an unresolved qualification gap, not a finding that the underlying report is false.
FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingMay 26, 2026
FDA / Federal Register Notice: Agency Information Collection Activities; Proposed Collection; Comment Request; Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act
FDA seeks comments on human drug compounding regulations.
What to do — members only.Become a member →Federal Registerprimary source ↗ - CAUTIONFEDGLP-1 CompoundingMay 26, 2026
Primary Source Monitoring: Agency Information Collection Activities; Proposed Collection; Comment Request; Human Drug Compounding Under Sections 503A and 503B of the Federal Fo…
FDA requests comments on drug compounding information collection.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORMAScope of PracticeMay 26, 2026
MA H5455: Regulating the operation of medical spas
Proposed Massachusetts bill to regulate the operation of med spas.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIMay 21, 2026
FDA inspection citations: Oakwood Laboratories LLC (4 observations)
FDA cites Oakwood Laboratories for quality and sterility issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORGAMulti-topicMay 19, 2026
GA State Medical Board: IV Hydration/Therapy Position Statement
Georgia board issues guidance on IV hydration therapies.
What to do — members only.Become a member →State Medical Boardprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIMay 19, 2026
FDA inspection citations: Novartis Pharma Stein AG (2 observations)
FDA cites Novartis Pharma for sterility issues; verify sourcing.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDNeuromodulatorsMay 19, 2026
Primary Source Monitoring: California Doctor Convicted of $45M Botox Fraud Scheme Targeting Medicare
California doctor convicted in Botox fraud scheme.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIMay 19, 2026
FDA inspection citations: Samchundang Pharm Co., Ltd. (8 observations)
FDA cites facility for sterile compounding issues; verify your sources.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIMay 15, 2026
FDA inspection citations: Unither Manufacturing LLC. (9 observations)
FDA cites Unither Manufacturing for issues related to sterility.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIMay 15, 2026
FDA inspection citations: Owen Biosciences Inc. (3 observations)
FDA cites Owen Biosciences for quality control violations.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIMay 15, 2026
FDA inspection citations: Emcure Pharmaceuticals Limited (7 observations)
FDA cites Emcure Pharmaceuticals for sterile process issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIMay 13, 2026
FDA inspection citations: InvaTech Pharma Solutions, LLC (6 observations)
Med spas should verify sourcing from InvaTech Pharma Solutions.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - CRITICALFEDGLP-1 CompoundingFDA: OAIMay 12, 2026
FDA Warning Letter: Fresenius Kabi Compounding, LLC (Drugs)
FDA Warning Letter issued to Fresenius Kabi Compounding, LLC.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORFEDMulti-topicMay 8, 2026
Primary Source Monitoring: Med Spa Owner Pleads Guilty to Performing Illegal Injections Using Unapproved Prescription Drugs
Guilty plea highlights risks of using unapproved injections.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIMay 5, 2026
FDA inspection citations: Zydus Lifesciences Limited (7 observations)
FDA cites Zydus Lifesciences for sterility and quality issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIMay 4, 2026
FDA inspection citations: Element Materials Technology Boston - Acton Inc. (4 observations)
Caution urged for med spas sourcing from a cited facility.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIMay 1, 2026
FDA inspection citations: Gvs Tm, Inc (14 observations)
FDA cites GVS TM, Inc; verify sourcing and remediation.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingMay 1, 2026
FDA / Federal Register Notice: List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act
FDA evaluates bulk drug substances; GLP-1 agents may be impacted.
What to do — members only.Become a member →Federal Registerprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIMay 1, 2026
FDA inspection citations: SnugZ USA, Inc. (9 observations)
FDA cites SnugZ USA for quality control issues; verify your supply.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingApr 30, 2026
FDA / Federal Register Notice: Determination That Ozempic (Semaglutide) Solution, 2 Milligrams Per 1.5 Milliliters Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
FDA ensures continued access to OZEMPIC for aesthetic practices.
What to do — members only.Become a member →Federal Registerprimary source ↗ - MONITORFEDMulti-topicApr 30, 2026
Primary Source Monitoring: Advisory Committee; Pharmacy Compounding Advisory Committee; Renewal
Pharmacy Compounding Advisory Committee renewed for continued oversight.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIApr 29, 2026
FDA inspection citations: Samson Pharmaceuticals, Inc (8 observations)
FDA cites Samson Pharmaceuticals for multiple compliance issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIApr 29, 2026
FDA inspection citations: American Red Cross Manchester Fixed Site (1 observation)
FDA cites facility for sterility issues impacting med spas.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIApr 24, 2026
FDA inspection citations: University of Vermont Health Network - Adirondack Blood Center (2 observations)
FDA cites facility for sterility issues; verify your sources.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIApr 24, 2026
FDA inspection citations: Hanlim Pharm Co. Ltd. (11 observations)
FDA cites Hanlim Pharm for sterility and validation issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - CRITICALTNNATIONALScope of PracticeApr 23, 2026
Source qualification pending
Consequential guidance is withheld while the exact primary source, scope or named-entity binding is reviewed. This is an unresolved qualification gap, not a finding that the underlying report is false.
LegiScanprimary source ↗ - MONITORCOMulti-topicApr 23, 2026
CO SB130: Medical Spas Deceptive Trade Practices
Colorado med spa drug-practices bill; postponed indefinitely in committee.
What to do — members only.Become a member →LegiScanprimary source ↗ - CRITICALFEDMulti-topicFDA: OAIApr 22, 2026
FDA Warning Letter: Active Cosmetics Manufacturing Inc (Drugs)
FDA cites Active Cosmetics Manufacturing for releasing OTC topical drugs after failed microbial tests, including S. aureus.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORFEDGLP-1 CompoundingApr 22, 2026
FDA recall (Class II): Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Bea…
Historical FDA recall D-0471-2026 covers Northwest Compounders semaglutide-glycine-cyanocobalamin injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials; Lot Number 01-27-2026@14S.5.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIApr 21, 2026
FDA inspection citations: Altaire Pharmaceuticals, Inc. (8 observations)
Caution: FDA cites facility for sterility issues; verify your sources.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - CAUTIONFEDMulti-topicFDA: OAIApr 20, 2026
FDA Warning Letter: Foshan Miwei Cosmetics Co., Ltd. (Drugs)
FDA cites Foshan Miwei Cosmetics for releasing OTC drug products without testing active-ingredient strength or microbes.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORFEDGLP-1 CompoundingApr 16, 2026
Primary Source Monitoring: Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for…
Pharmacy Compounding Advisory Committee discusses new bulk substances.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIApr 14, 2026
FDA inspection citations: Rohto-Mentholatum (Vietnam) Co., Ltd. (8 observations)
FDA cites sterile compounder for product quality concerns.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORCTScope of PracticeApr 9, 2026
CT HB05399: An Act Concerning Dentistry.
CT HB05399 revises dental supervision requirements; effective October 1, 2026.
What to do — members only.Become a member →LegiScanprimary source ↗ - CAUTIONMEMulti-topicApr 8, 2026
ME LD2201: An Act to Implement Certain Recommendations Related to the Regulatory Review and Approval of Certain Health Care Transactions Involving Private Equity Companies, Hedge Funds or Management Services Organizations from the Commission to Evaluate the Scope of Regulatory Review and Oversight over Health Care Transactions That Impact the Delivery of Health Care Services in the State
Notification rules impact med spas working with private equity.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDMulti-topicApr 7, 2026
Primary Source Monitoring: Med Spa Owner Pleads Guilty to Performing Thousands of Injections Using Counterfeit Products
Med spa owner guilty of using counterfeit injection products.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIApr 2, 2026
FDA inspection citations: Baxter Healthcare Corporation (9 observations)
FDA cites Baxter for sterility concerns; verify your sources.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - CAUTIONFEDMulti-topicApr 2, 2026
FDA Warning Letter: Purolea Cosmetics Lab (Drugs)
FDA cites Purolea Cosmetics Lab for insects and filth in its plant and for untested homeopathic drug products.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORFEDScope of PracticeApr 1, 2026
Primary Source Monitoring: Utah Licensed Osteopathic Physician Indicted for Allegedly Receiving Misbranded Drugs from China and Selling them to Patients
Indictment of a physician raises concerns for med spas on drug sourcing.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - CAUTIONFEDMulti-topicApr 1, 2026
FDA Warning Letter: Pure Indulgence Aesthetics (Drugs)
FDA says a Texas med spa administered far more Botox than it bought from AbbVie, and so had sourced toxin from unauthorized suppliers.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONFEDGLP-1 CompoundingMar 31, 2026
FDA Warning Letter: Mile High Compounds (Drugs)
FDA says the "research-only" semaglutide, tirzepatide and retatrutide sold by Mile High Compounds are unapproved injectable drugs. The firm's own weight-loss dosing guides, shared through its online forum, were FDA's evidence that the products were meant for people.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONFEDGLP-1 CompoundingMar 31, 2026
FDA Warning Letter: Gram Peptides (Drugs)
FDA says GRAM Peptides' "research use only" retatrutide and tirzepatide, sold with bacteriostatic water, are unapproved drugs.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORKYScope of PracticeMar 27, 2026
KY HB885: an Act relating to cosmetology.
Supervision requirements for esthetic practices in Kentucky.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIMar 19, 2026
FDA inspection citations: PReye LLC (4 observations)
Med spas should check sourcing from PReye LLC after FDA findings.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - CAUTIONFEDAesthetic DevicesMar 18, 2026
FDA device recall (Class II): Clarity II Laser System; Model No. 1110200210.
FDA recalls Clarity II Laser System for safety concerns.
What to do — members only.Become a member →FDA Device Recallprimary source ↗ - MONITORFLScope of PracticeMar 13, 2026
FL H1429: Licensure of Medical Spas
Florida med spa licensure bill; died in subcommittee.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFLMulti-topicMar 13, 2026
FL S1728: Licensure of Medical Spas
Proposed licensure for medical spas would enhance oversight and compliance.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIMar 12, 2026
FDA inspection citations: Corixa Corporation (1 observation)
FDA inspection cited Corixa Corporation for environmental monitoring issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - CAUTIONFEDGLP-1 CompoundingMar 11, 2026
Source qualification pending
Consequential guidance is withheld while the exact primary source, scope or named-entity binding is reviewed. This is an unresolved qualification gap, not a finding that the underlying report is false.
FDA Enforcementprimary source ↗ - CRITICALFEDGLP-1 CompoundingMar 11, 2026
FDA recall (Class II): Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061,…
Historical FDA recall D-0393-2026 covers Nomida semaglutide injection, 2 mg x 5; Lot 240903, exp 9/30/2026.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingMar 11, 2026
FDA recall (Class II): Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061, …
FDA recalls compounded GLP-1 product over sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingMar 11, 2026
FDA recall (Class II): Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 843…
Important recall on compounded Semaglutide products affecting med spas.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingMar 11, 2026
FDA recall (Class II): Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061, NDC …
FDA recalls Tirzepatide injection over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CAUTIONFEDGLP-1 CompoundingMar 11, 2026
FDA recall (Class II): Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061, …
Historical FDA recall D-0395-2026 covers Nomida tirzepatide injection, 15 mg x 4; Lot 240709, exp 7/31/2026.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIMar 6, 2026
FDA inspection citations: Pharmaceutics International, Inc. (9 observations)
FDA cites compounding facility for sterility and quality concerns.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - CAUTIONINNATIONALMulti-topicMar 5, 2026
Source qualification pending
Consequential guidance is withheld while the exact primary source, scope or named-entity binding is reviewed. This is an unresolved qualification gap, not a finding that the underlying report is false.
LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIMar 5, 2026
FDA inspection citations: Sharp Sterile Manufacturing, LLC (6 observations)
FDA cites facility for sterilization and procedural issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORWVScope of PracticeMar 2, 2026
WV SB486: Relating to Wv Board of Barbers and Cosmetologists
'Master aesthetician' role expands service capabilities in WV.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 27, 2026
FDA inspection citations: Gasco Industrial Corp. (13 observations)
FDA cites facility for issues potentially affecting product quality.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 27, 2026
FDA inspection citations: Tan-Alize Kozmetik ve Temizlik Urunleri Sanayi ve Ticaret A.S. (7 observations)
FDA inspection reveals quality concerns for a facility supplying med spas.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 27, 2026
FDA inspection citations: Gallant Pet Inc (10 observations)
FDA inspection reveals sterility issues at Gallant Pet Inc.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIFeb 26, 2026
FDA inspection citations: CoreRX Inc. (7 observations)
FDA cites CoreRX Inc. for multiple quality control issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFeb 23, 2026
Primary Source Monitoring: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Human Drug Compounding Under Sectio…
Comment period open on federal compounding information requirements.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDGLP-1 CompoundingFeb 23, 2026
FDA / Federal Register Notice: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act
FDA notice may impact GLP-1 compounding practices at med spas.
What to do — members only.Become a member →Federal Registerprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 20, 2026
FDA inspection citations: Staska Pharmaceuticals, Inc. (3 observations)
FDA cites Staska Pharmaceuticals for quality and sterility issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIFeb 18, 2026
FDA inspection citations: Gilead Sciences, Inc. (7 observations)
FDA cites Gilead Sciences for sterility and quality control issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORWVScope of PracticeFeb 16, 2026
WV HB5538: To expand licensing opportunities and safety regulation in the esthetics industry
Licensing bill expands esthetics practices in WV.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 13, 2026
FDA inspection citations: K.C. Pharmaceuticals, Inc (13 observations)
FDA cites K.C. Pharmaceuticals for sterility concerns.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORRIOwnership/CPOMFeb 12, 2026
RI H7721: Establishes the Rhode Island Ban on the Corporate Practice of Medicine Act.
RI Bill H7721 may change corporate practice for med spas.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 12, 2026
FDA inspection citations: Tropical Seas, Inc. (8 observations)
FDA cites Tropical Seas for multiple quality concerns.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORAZScope of PracticeFeb 10, 2026
AZ HB4047: Medical spas; licensure; regulation
Licensure requirements for med spas in Arizona.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIFeb 6, 2026
FDA inspection citations: Csl Plasma Inc (2 observations)
FDA cites CSL Plasma for contamination and product deviation issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORRIOwnership/CPOMFeb 6, 2026
RI S2459: Establishes the Rhode Island Ban on the Corporate Practice of Medicine Act.
Rhode Island's S2459 could impact med spa ownership practices.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 6, 2026
FDA inspection citations: Eugia Pharma Specialities Limited (11 observations)
FDA cites Eugia Pharma for serious sterility issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIFeb 6, 2026
FDA inspection citations: Novartis Pharmaceuticals Corporation (3 observations)
Novartis Pharmaceuticals cited by FDA for sterile drug procedures issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIFeb 6, 2026
FDA inspection citations: Alcami Carolinas Corporation (6 observations)
Check sourcing from Alcami Carolinas after FDA citations.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 5, 2026
FDA inspection citations: Ony Biotech, Inc. (3 observations)
FDA inspection raises concerns about drug quality at ONY Biotech.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 5, 2026
FDA inspection citations: NexCell Scientific Inc (13 observations)
FDA cites NexCell Scientific for multiple quality control issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIFeb 5, 2026
FDA inspection citations: Nice-Pak Products, LLC (4 observations)
FDA cites Nice-Pak Products for facility inspection issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORILOwnership/CPOMFeb 5, 2026
IL SB3463: Health Facilities Planning
SB3463 alters ownership change rules for health care facilities in Illinois.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORMSGLP-1 CompoundingFeb 3, 2026
MS SB2544: Mississippi Active Pharmaceutical Ingredient Quality Assurance Act; enact to impose certain provisions for compounding.
Mississippi compounding-ingredient quality bill; died in committee.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIFeb 3, 2026
FDA inspection citations: Iso-Tex Diagnostics, Inc. (5 observations)
FDA cites Iso-Tex Diagnostics for quality and sterility issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIJan 30, 2026
FDA inspection citations: Hibrow Healthcare Private Limited (2 observations)
FDA cites facility for drug quality concerns; verify your suppliers.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIJan 30, 2026
FDA inspection citations: Element Materials Technology Oakland-Concord (6 observations)
FDA cites facility for quality issues impacting compounded products.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIJan 29, 2026
FDA inspection citations: American Regent, Inc. (4 observations)
FDA inspection reveals citations at American Regent, Inc.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORHIGLP-1 CompoundingJan 28, 2026
HI SB3195: Relating To Drugs For Weight Loss.
HI SB3195 mandates coverage for GLP-1 weight loss drugs.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDAesthetic DevicesJan 28, 2026
FDA device recall (Class II): Brand Name: Leaseir Product Name: Leaseir Mhr Xcell Model/Catalog Number: Mhr 110-b Software Version: 1.5.0.0 Product D…
Leaseir MHR Xcell laser recalled for safety issues.
What to do — members only.Become a member →FDA Device Recallprimary source ↗ - MONITORMAMulti-topicJan 27, 2026
MA H5087: Regulating the operation of medical spas
Proposed Massachusetts med spa bill; superseded by a new draft, H5455.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingJan 22, 2026
FDA inspection citations: Anika Therapeutics, Inc. (4 observations)
FDA cites Anika Therapeutics for quality and sterility issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIJan 22, 2026
FDA inspection citations: Excel Vision (11 observations)
FDA cites Excel Vision for sterility and quality issues in inspection.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORIAScope of PracticeJan 20, 2026
IA HSB591: A bill for an act establishing the medical spa oversight Act, and making penalties applicable.
Proposed Iowa Medical Spa Oversight Act, with penalties.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIJan 9, 2026
FDA inspection citations: OneBlood, Inc. (1 observation)
FDA cites OneBlood for sterile compounding issues.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - CRITICALFEDGLP-1 CompoundingJan 7, 2026
FDA recall (Class II): Wegovy (Semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…
Historical FDA recall D-0244-2026 covers Wegovy 0.5 mg/0.5 mL pens; Lot #: RZFHD52, RZFHW93; Exp Date 10/31/2026.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIJan 7, 2026
FDA inspection citations: South Bend Medical Foundation, Inc. (1 observation)
FDA cites facility for sterile preparation issues impacting compounding.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingJan 7, 2026
FDA recall (Class II): Wegovy (Semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 B…
FDA recalls Wegovy due to safety concerns; med spas must act.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIDec 22, 2025
FDA inspection citations: Blaine Labs Inc (12 observations)
FDA cites Blaine Labs for quality issues; med spas should verify sourcing.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIDec 19, 2025
FDA inspection citations: International Medication Systems Ltd. (8 observations)
FDA cites facility for sterility issues affecting med spas.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDMulti-topicDec 18, 2025
Primary Source Monitoring: Doctor Indicted for Orchestrating $45M Botox Fraud Scheme Targeting Medicare
Doctor indicted in $45M Botox fraud scheme targeting Medicare.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: VAIDec 17, 2025
FDA inspection citations: Wyeth Pharmaceutical Division of Wyeth Holdings LLC (4 observations)
FDA cites Wyeth for sterility issues; verify your sourcing.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORPAScope of PracticeDec 16, 2025
PA HB1881: Further providing for pharmacy technician and pharmacy technician trainee registration, qualifications and supervision; providing for administration of injectable medications, biologicals and immunizations, for clinical laboratory certificate and for report on pharmacy-administered vaccines; and making a repeal.
PA bill may expand pharmacy technicians' role in injectables.
What to do — members only.Become a member →LegiScanprimary source ↗ - MONITORFEDGLP-1 CompoundingFDA: OAIDec 16, 2025
FDA inspection citations: Bello Bio LLC (13 observations)
FDA cites Bello Bio LLC for multiple sterile production violations.
What to do — members only.Become a member →FDA Inspection Citationprimary source ↗ - MONITORFEDScope of PracticeDec 12, 2025
Primary Source Monitoring: Med Spa Owner Agrees to Plead Guilty to Performing Illegal Injections Using Unapproved Prescription Drugs
Legal repercussions for med spas using unapproved injection drugs.
What to do — members only.Become a member →Primary Source Monitoringprimary source ↗
Browse the full archive → Every material change on record, grouped by year — including changes older than the 18 months shown above.